Exploring the Sizable Growth of the Global Clinical Biomarkers Market: Influences, Key Players, and Forecast Until 2029

Forecasted Increases in Clinical Biomarkers Market Size: What Are The Numbers?

• The clinical biomarkers market size has grown in recent years and will expand from $30.78 billion in 2024 to $33.85 billion in 2025, representing a compound annual growth rate (CAGR) of 10.0%.
• Primary causes for growth in the historic period include increased prevalence of chronic disease, focus on personalized medicine and targeted therapies, and support from regulatory bodies.
• The market is predicted to surge to $52.8 billion in 2029 at a CAGR of 11.8%. The key drivers for this forecasted large increase are the continued development of companion diagnostics, heightened focus on early diagnosis and disease prevention, along with the expanding applications in precision oncology and neurodegenerative diseases, and infectious disease control.

High Cancer Prevalence: What Is Its Impact on the Growth of the Clinical Biomarkers Market?

The high cancer prevalence is a major factor propelling the growth of the clinical biomarker market. Cancer, defined as abnormal cell growth, poses significant threats to health and wellbeing. Clinical biomarkers play an instrumental role in preventing cancer through aiding early detection, risk assessment, and monitoring individuals at high risk. For instance, Cancer Research UK predicts an increase in new kidney cancer cases from roughly 16,300 to about 21,900 by 2038-2040, indicating a 15% increase in this period. Such trends underscore the role of high cancer prevalence in spurring the clinical biomarker market growth.

Request A Free Sample Copy here: https://www.thebusinessresearchcompany.com/sample.aspx?id=12670&type=smp

Who Are the Key Players Driving Clinical Biomarkers Market Growth?

Prominent companies operating in the clinical biomarkers market include:

• Johnson and Johnson Services Inc.
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Merck KGaA
• Becton Dickinson and Company
• Eurofins Scientific
• Agilent Technologies Inc.
• Epigenomics AG
• Grifols S.A.
• Illumina Inc.
• BioMerieux SA.
• Charles River Laboratories International Inc.
• PerkinElmer Inc.
• Sartorius AG
• Sysmex Corporation
• Waters Corporation
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Qiagen N.V.
• Myriad Genetics Inc.
• Luminex Corporation
• Veracyte Inc.
• Centogene N.V.
• NanoString Technologies Inc.
• Enzo Biochem Inc.
• Biocartis Group NV
• Agendia Inc.
• Siemens Healthcare Private Limited

Key Trends in the Clinical Biomarkers Market: What Are They?

• AI-powered biomarker discovery
• Machine learning integration
• Multi-omics integration
• Technological innovations
• Partnerships between key players

What Are The Segments Of The Global Clinical Biomarkers Market?

The clinical biomarkers market is segmented by:

1) Offering: Product, Service
2) Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies
3) Clinical Area: Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Immunological Biomarker, Non-Invasive Prenatal Testing, Other Clinical Areas
4) Application: Clinical Diagnostic, Translational Research
5) End User: Contract Research Organizations (CROs), Research And Academic Laboratories, Biopharmaceutical And Biotech Companies, Diagnostic Centers, Other End Users

Which Region is Dominating the Clinical Biomarkers Market?

In 2024, North America was the largest region in the clinical biomarkers market. Other regions covered in the clinical biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery here: https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

What Is Covered In The Clinical Biomarkers Market Global Market Report?

- Market Size Analysis: Analyze the Clinical Biomarkers Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Clinical Biomarkers Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Clinical Biomarkers Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Clinical Biomarkers Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report here: https://www.thebusinessresearchcompany.com/customise?id=12670&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.